CA1263087A - Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions - Google Patents

Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions

Info

Publication number
CA1263087A
CA1263087A CA000501011A CA501011A CA1263087A CA 1263087 A CA1263087 A CA 1263087A CA 000501011 A CA000501011 A CA 000501011A CA 501011 A CA501011 A CA 501011A CA 1263087 A CA1263087 A CA 1263087A
Authority
CA
Canada
Prior art keywords
formulation according
fatty material
dergocrine
dihydroergotamine
swelling substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000501011A
Other languages
English (en)
French (fr)
Inventor
Othmar Zuger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858502889A external-priority patent/GB8502889D0/en
Priority claimed from GB858517604A external-priority patent/GB8517604D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Application granted granted Critical
Publication of CA1263087A publication Critical patent/CA1263087A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA000501011A 1985-02-05 1986-02-03 Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions Expired CA1263087A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8502889 1985-02-05
GB858502889A GB8502889D0 (en) 1985-02-05 1985-02-05 Co-dergocrine compositions
GB8517604 1985-07-12
GB858517604A GB8517604D0 (en) 1985-07-12 1985-07-12 Dihydroergotamine compositions

Publications (1)

Publication Number Publication Date
CA1263087A true CA1263087A (en) 1989-11-21

Family

ID=26288767

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000501011A Expired CA1263087A (en) 1985-02-05 1986-02-03 Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions

Country Status (24)

Country Link
JP (1) JPS61183225A (it)
KR (1) KR920010388B1 (it)
AU (1) AU597570B2 (it)
BE (1) BE904152A (it)
CA (1) CA1263087A (it)
CH (1) CH667592A5 (it)
CY (1) CY1604A (it)
DE (1) DE3602577A1 (it)
DK (1) DK167138B1 (it)
ES (1) ES8800040A1 (it)
FR (1) FR2576787B1 (it)
GB (1) GB2170407B (it)
GR (1) GR860310B (it)
HK (1) HK57191A (it)
HU (1) HU195729B (it)
IE (1) IE59293B1 (it)
IT (1) IT1191255B (it)
LU (1) LU86289A1 (it)
NL (1) NL8600161A (it)
NZ (1) NZ215020A (it)
PH (1) PH23384A (it)
PT (1) PT81954B (it)
SE (1) SE8600496L (it)
SG (1) SG56191G (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2610827B1 (fr) * 1987-02-18 1991-09-13 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
YU47044B (sh) * 1987-03-11 1994-12-28 LEK TOVARNA FARMACEVTSKIH IN KEMIČNIH IZDELKOV n.sol.o. Postupak za dobijanje tableta sa produženim delovanjem na bazi hidroksipropil-metilceluloze velike molekularne mase
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
RU2256454C2 (ru) * 1999-12-03 2005-07-20 Полишем С.А. Способы получения фармацевтических композиций алкалоидов спорыньи с пролонгированным действием, характеризующихся улучшенной биодоступностью, и содержащие указанные алкалоиды композиции
US20030153620A1 (en) 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
NZ504526A (en) * 2000-05-12 2003-05-30 Meracol Corp Ltd Treating herpes simplex symptoms using a mixture of cetyl myristate and cetyl palmitate
WO2001085163A1 (en) * 2000-05-12 2001-11-15 Meracol Corporation Limited Treating eczema and/or psoriasis
US6696491B2 (en) 2000-05-12 2004-02-24 Meracol Corporation Limited Treating irritable bowel syndrome or disease
WO2003026640A1 (en) * 2001-09-28 2003-04-03 Meracol Corporation Limited Treating food allergies and/or food intolerances
CN111297815B (zh) * 2020-04-29 2022-04-15 宝利化（南京）制药有限公司 一种甲磺酸二氢麦角碱缓释片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
DE3124983A1 (de) * 1981-06-25 1983-01-20 Meditest Inst Fuer Medizinisch Arzneiformen zur oralen verabreichung
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3303616A1 (de) * 1982-02-12 1983-08-25 Sandoz-Patent-GmbH, 7850 Lörrach Mutterkornalkaloide, verfahren zu deren herstellung sowie diese verbindungen enthaltende pharmazeutische zubereitungen
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
GB8413795D0 (en) * 1984-05-30 1984-07-04 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
ES551635A0 (es) 1987-10-16
JPS61183225A (ja) 1986-08-15
NL8600161A (nl) 1986-09-01
DK52086A (da) 1986-08-06
DE3602577A1 (de) 1986-08-28
PH23384A (en) 1989-07-26
PT81954A (en) 1986-03-01
IT8647620A0 (it) 1986-02-05
SE8600496D0 (sv) 1986-02-04
SG56191G (en) 1991-08-23
KR860006265A (ko) 1986-09-09
HUT41984A (en) 1987-06-29
IE59293B1 (en) 1994-02-09
KR920010388B1 (ko) 1992-11-27
HK57191A (en) 1991-08-02
CY1604A (en) 1992-04-03
GB2170407A (en) 1986-08-06
FR2576787A1 (fr) 1986-08-08
NZ215020A (en) 1989-07-27
CH667592A5 (de) 1988-10-31
ES8800040A1 (es) 1987-10-16
GR860310B (en) 1986-05-27
IT1191255B (it) 1988-02-24
LU86289A1 (fr) 1986-09-02
FR2576787B1 (fr) 1990-01-12
IE860291L (en) 1986-08-05
DK167138B1 (da) 1993-09-06
BE904152A (fr) 1986-08-04
GB2170407B (en) 1988-10-26
DK52086D0 (da) 1986-02-03
SE8600496L (sv) 1986-08-06
AU597570B2 (en) 1990-06-07
AU5294286A (en) 1986-08-14
GB8602602D0 (en) 1986-03-12
PT81954B (pt) 1988-07-01
HU195729B (en) 1988-07-28

Similar Documents

Publication Publication Date Title
SU1743332A3 (ru) Способ получени таблеток
BG64168B1 (bg) Бързоразтворима таблета на галантамин хидробромид
CA1263087A (en) Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions
GB2196852A (en) Sustained release composition
US5399360A (en) Pharmaceutical compositions
GB2154874A (en) Bromocriptine compositions
US5069911A (en) Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions
UA65652C2 (uk) Таблетка з регульованим вивільненням бетагістину та спосіб її виготовлення
PL191767B1 (pl) Stabilizowane przed racemizacją stałe lub ciekłe preparaty farmaceutyczne zawierające jako składnik czynny cilansetron, sposób wytwarzania stabilizowanych przed racemizacją stałych preparatów farmaceutycznych zawierających jako składnik czynny cilansetron oraz zastosowanie dopuszczalnych fizjologicznie rozpuszczalnych w wodzie kwaśnych dodatków
GB2181053A (en) Controlled release formulation
AU756338B2 (en) Stabile compositions comprising levosimendan and alginic acid
CA1256374A (en) Bromocriptine compositions
KR920008817B1 (ko) 조절된 방출성(서방성) 약학적 제제의 제조방법.
US4152435A (en) Compositions and methods to treat hypertension comprising a pyridazine and N-amidino-2-(2,6-dichlorophenyl) acetamide
JPH0466846B2 (it)
US3629471A (en) Tranquilizing compositions and methods
KR950007229B1 (ko) 케토티펜을 함유한 약학적 조성물
JPH0337529B2 (it)

Legal Events

Date Code Title Description
MKLA Lapsed